Humana Inc 10-Q Filing

Ticker: HUM · Form: 10-Q · Filed: Jul 31, 2024 · CIK: 49071

Humana Inc 10-Q Filing Summary
FieldDetail
CompanyHumana Inc (HUM)
Form Type10-Q
Filed DateJul 31, 2024
Pages16
Reading Time20 min
Key Dollar Amounts$0.16
Sentimentneutral

Sentiment: neutral

FAQ

What type of filing is this?

This is a 10-Q filing submitted by Humana Inc (ticker: HUM) to the SEC on Jul 31, 2024.

What are the key financial figures in this filing?

Key dollar amounts include: $0.16 (ange on which registered Common stock, $0.16 2/3 par value HUM New York Stock Exchan).

How long is this filing?

Humana Inc's 10-Q filing is 16 pages with approximately 4,896 words. Estimated reading time is 20 minutes.

Where can I view the full 10-Q filing?

The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.

Filing Stats: 4,896 words · 20 min read · ~16 pages · Grade level 16.6 · Accepted 2024-07-31 14:08:48

Key Financial Figures

  • $0.16 — ange on which registered Common stock, $0.16 2/3 par value HUM New York Stock Exchan

Filing Documents

: Financial Information

Part I: Financial Information

Financial Statements

Item 1. Financial Statements Condensed Consolidated Balance Sheets (Unaudited) at June 3 0 , 2024 and December 31, 2023 3 Condensed Consolidated Statements of Income (Unaudited) for the three and six months ended June 30 , 2024 and 2023 4 Condensed Consolidated Statements of Comprehensive Income (Unaudited) for the three and six months ended June 30 , 2024 and 2023 5 Condensed Consolidated Statements of Stockholders' Equity (Unaudited) for the three and six months ended June 30 , 2024 and 2023 6 Condensed Consolidated Statements of Cash Flows (Unaudited) for the six months ended June 30 , 2024 and 2023 8 Notes to Condensed Consolidated Financial Statements (Unaudited) 10

Management's Discussion and Analysis of Financial Condition and Results of Operations

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 35

Quantitative and Qualitative Disclosures about Market Risk

Item 3. Quantitative and Qualitative Disclosures about Market Risk 50

Controls and Procedures

Item 4. Controls and Procedures 50

: Other Information

Part II: Other Information

Legal Proceedings

Item 1. Legal Proceedings 51

Risk Factors

Item 1A. Risk Factors 51

Unregistered Sales of Equity Securities and Use of Proceeds

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 51

Defaults Upon Senior Securities

Item 3. Defaults Upon Senior Securities 51

Mine Safety Disclosures

Item 4. Mine Safety Disclosures 51

Other Information

Item 5. Other Information 52

Exhibits

Item 6. Exhibits 53

Signatures

Signatures 54 Certifications Humana Inc. CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) June 30, 2024 December 31, 2023 (in millions, except share amounts) ASSETS Current assets: Cash and cash equivalents $ 5,501 $ 4,694 Investment securities 17,424 16,626 Receivables, net of allowances of $ 96 in 2024 and $ 88 in 2023 4,090 2,035 Other current assets 5,843 6,631 Total current assets 32,858 29,986 Property and equipment, net 2,821 3,030 Long-term investment securities 388 382 Equity method investments 736 740 Goodwill 9,567 9,550 Other long-term assets 3,723 3,377 Total assets $ 50,093 $ 47,065 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Benefits payable $ 11,446 $ 10,241 Trade accounts payable and accrued expenses 6,527 6,569 Book overdraft 355 353 Unearned revenues 313 266 Short-term debt 1,149 1,443 Total current liabilities 19,790 18,872 Long-term debt 11,746 10,213 Other long-term liabilities 1,829 1,662 Total liabilities 33,365 30,747 Commitments and Contingencies (Note 13) Stockholders' equity: Preferred stock, $ 1 par; 10,000,000 shares authorized; none issued — — Common stock, $0.16 2/3 par; 300,000,000 shares authorized; 198,718,810 shares issued at June 30, 2024 and 198,690,082 shares issued at December 31, 2023 33 33 Capital in excess of par value 3,420 3,346 Retained earnings 28,745 27,540 Accumulated other comprehensive loss ( 1,122 ) ( 999 ) Treasury stock, at cost, 78,317,149 shares at June 30, 2024 and 76,465,862 shares at December 31, 2023 ( 14,405 ) ( 13,658 ) Total stockholders' equity 16,671 16,262 Noncontrolling interests 57 56 Total equity 16,728 16,318 Total liabilities and equity $ 50,093 $ 47,065 See accompanying notes to condensed consolidated financial statements. 3 Humana Inc. CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Unaudited) Three months ended June 30, Six Months Ended June 30, 2024 2023 2024 2023 (in millions, except per share results) Revenues

View Full Filing

View this 10-Q filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.